Tenderwize
Retour à la recherche

Open House Originale Agreement for Isavuconazole

Techniker Krankenkasse·Hamburg, Germany·Deadline Oct 30, 2027 · 430 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-29 - Isavuconazol

62/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

62 / 100

Complexité

56 / 100

Facteurs de risque

The notice states that offers/contracts cannot be submitted via the portal; submission must be by email with qualified...

Eligibility is limited to pharmaceutical undertakings for the relevant product with valid authorization and no exclusio...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Supply-side open-house rebate agreement for Isavuconazole.
  • Conclusion of rebate contracts under Section 130c(1) SGB V.
Afficher le résumé complet

Open-house supply arrangement by Techniker Krankenkasse for the pharmaceutical product Isavuconazole (CPV 33600000). The notice says all suitable pharmaceutical companies that meet the stated legal and self-declaration requirements may join during the contract period, with no exclusivity and no individual negotiation. Contract term is up to 24 months from 01.11.2025 to 31.10.2027, with possible automatic earlier end if patent/market exclusivity ends. No contract value is stated. Electronic submission via the tender portal is not allowed; contracts must be sent electronically by email with qualified electronic signature or by post. Procurement documents are available online, but no extracted document text beyond the notice was provided.

Risques

The notice states that offers/contracts cannot be submitted via the portal; submission must be by email with qualified...

Eligibility is limited to pharmaceutical undertakings for the relevant product with valid authorization and no exclusio...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Participant must be a pharmaceutical company within the meaning of German medicinal products law for the relevant product.
  • Company seat must be in the scope of the AMG, another EU Member State, or another EEA state.
  • Valid marketing authorization for the relevant medicinal product and/or other right to place it on the market in own name.

Critères d'attribution

Lot 1

No explicit lot-specific award criteria provided; the notice indicates this is an open-house arrangement with uniform conditions.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House Originale Agreement for Isavuconazole

Single lot for supply-side open-house rebate agreements for Isavuconazole with TK. Scope is nationwide in Germany. The lot information comes from structured notice data and the TED XML notice. No separate lot value is stated.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Oct 2025 - Oct 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No explicit lot-specific award criteria provided; the notice indicates this is an open-house arrangement with uniform conditions.

Date limite

Deadline Oct 30, 2027

Détails de la procédure

Date de publication
22 Sep 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
622464-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3